Cite
Elexacaftor/tezacaftor/ivacaftor and mental health: A workshop report from the Cystic Fibrosis Foundation's Prioritizing Research in Mental Health working group.
MLA
Bathgate, C. J., et al. “Elexacaftor/Tezacaftor/Ivacaftor and Mental Health: A Workshop Report from the Cystic Fibrosis Foundation’s Prioritizing Research in Mental Health Working Group.” Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, Nov. 2024. EBSCOhost, https://doi.org/10.1016/j.jcf.2024.11.006.
APA
Bathgate, C. J., Fedele, D. A., Tillman, E. M., He, J., Everhart, R. S., Reznikov, L. R., Liu, F. F., Kirby, K., Raffensperger, K., Traver, K., Riekert, K. A., Powers, S. W., & Georgiopoulos, A. M. (2024). Elexacaftor/tezacaftor/ivacaftor and mental health: A workshop report from the Cystic Fibrosis Foundation’s Prioritizing Research in Mental Health working group. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. https://doi.org/10.1016/j.jcf.2024.11.006
Chicago
Bathgate, C J, D A Fedele, E M Tillman, J He, R S Everhart, L R Reznikov, F F Liu, et al. 2024. “Elexacaftor/Tezacaftor/Ivacaftor and Mental Health: A Workshop Report from the Cystic Fibrosis Foundation’s Prioritizing Research in Mental Health Working Group.” Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, November. doi:10.1016/j.jcf.2024.11.006.